Clarivate (CLVT) – Research Analysts’ Recent Ratings Changes

Several brokerages have updated their recommendations and price targets on shares of Clarivate (NYSE: CLVT) in the last few weeks:

• 12/29/2025 – Clarivate had its “sell (e+)” rating reaffirmed by analysts at Weiss Ratings.
• 12/27/2025 – Clarivate was downgraded by analysts at Wall Street Zen from a “buy” rating to a “hold” rating.
• 12/22/2025 – Clarivate had its “sell (e+)” rating reaffirmed by analysts at Weiss Ratings.
• 12/17/2025 – Clarivate had its “underweight” rating reaffirmed by analysts at Morgan Stanley. They now have a $3.00 price target on the stock, down previously from $5.00.
• 12/15/2025 – Clarivate had its “sell (e+)” rating reaffirmed by analysts at Weiss Ratings.
• 12/8/2025 – Clarivate had its “sell (e+)” rating reaffirmed by analysts at Weiss Ratings.
• 12/6/2025 – Clarivate was upgraded by analysts at Wall Street Zen from a “hold” rating to a “buy” rating.
• 12/1/2025 – Clarivate had its “sell (e+)” rating reaffirmed by analysts at Weiss Ratings.
• 11/17/2025 – Clarivate had its “sell (d-)” rating reaffirmed by analysts at Weiss Ratings.
• 11/5/2025 – Clarivate had its “sell (e+)” rating reaffirmed by analysts at Weiss Ratings.

Insider Buying and Selling at Clarivate

In other Clarivate news, insider Bar Veinstein sold 309,902 shares of the business’s stock in a transaction dated Monday, December 1st. The stock was sold at an average price of $3.74, for a total transaction of $1,159,033.48. Following the completion of the sale, the insider owned 848,811 shares of the company’s stock, valued at approximately $3,174,553.14. The trade was a 26.75% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Kenneth L. Cornick purchased 500,000 shares of the firm’s stock in a transaction on Friday, October 31st. The stock was bought at an average price of $3.38 per share, with a total value of $1,690,000.00. Following the acquisition, the director owned 775,000 shares in the company, valued at $2,619,500. This trade represents a 181.82% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. In the last three months, insiders acquired 2,285,000 shares of company stock worth $7,688,800. 23.18% of the stock is owned by corporate insiders.

Clarivate plc is a global information and analytics company that provides insights and workflow solutions to accelerate the pace of innovation. The company delivers proprietary data, analytics, and expertise to support research and development in the life sciences, intellectual property management, academic institutions, government agencies, and corporations. Its core offerings include citation and patent databases, drug pipeline analytics, trademark research tools, regulatory compliance solutions, and market intelligence platforms.

Originally part of Thomson Reuters’ Intellectual Property & Science division, Clarivate was established as an independent entity in 2016 following a spin-off transaction.